Bionik Laboratories Quick Ratio (BNKL) starting from the fourth quarter 2023 to fourth quarter 2022, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Bionik Laboratories Corp   (BNKL)

Bionik Laboratories 's Quick Ratio

BNKL's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the fourth quarter 2023, Quick Ratio fell to 0.19 below Bionik Laboratories Corp average.

Within Medical Equipment & Supplies industry 211 other companies have achieved higher Quick Ratio than Bionik Laboratories in fourth quarter 2023. While Quick Ratio total ranking in the fourth quarter 2023 has deteriorated compared to the prior quarter from 3327 to 4098.

Explain Quick Ratio?
How much Cash & cash equivalents BNKL´s has?
What are BNKL´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BNKL Quick Ratio (Mar 31 2023)
Q4		 (Dec 31 2022)
Q3		 (Sep 30 2022)
Q2		 (Jun 30 2022)
Q1		 (Mar 31 2022)
Q4
Y / Y Current Liabilities Change 54.77 % -78.78 % -79.36 % -54.81 % -63.57 %
Y / Y Cash & cash equivalent Change -78.54 % -79.67 % -91.67 % 145.35 % 227.34 %
Quick Ratio MRQ 0.19 0.33 0.2 0.79 1.33
BNKL's Total Ranking # 4098 # 3327 # 3551 # 3613 # 1860
Seq. Current Liabilities Change 10.4 % 2.95 % 20.08 % 13.4 % -84.86 %
Seq. Cash & cash equivalent Change -37.63 % 72.27 % -70.07 % -33.27 % -40.91 %



Quick Ratio fourth quarter 2023 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 212
Healthcare Sector # 1076
Overall Market # 4098


Quick Ratio Statistics
High Average Low
98.98 4.12 0.02
(Dec 31 2012)   (Sep 30 2017)




Financial Statements
Bionik Laboratories 's Current Liabilities $ 2 Millions Visit BNKL's Balance sheet
Bionik Laboratories 's Cash & cash equivalent $ 0 Millions Visit BNKL's Balance sheet
Source of BNKL's Sales Visit BNKL's Sales by Geography


Cumulative Bionik Laboratories 's Quick Ratio

BNKL's Quick Ratio for the trailling 12 Months

BNKL Quick Ratio

 (Mar 31 2023)
12 Months		 (Dec 31 2022)
12 Months		 (Sep 30 2022)
12 Months		 (Jun 30 2022)
12 Months		 (Mar 31 2022)
12 Months
Y / Y Current Liabilities TTM Growth -67.42 % -73.46 % -39.47 % 4.26 % -1.06 %
Y / Y Cash & cash equivalent TTM Growth -73.41 % -52.63 % 3.92 % 237.57 % 103.09 %
Quick Ratio TTM 0.35 0.6 0.47 0.5 0.43
Total Ranking TTM # 4597 # 366 # 1513 # 4574 # 4574
Seq. Current Liabilities TTM Growth 11.18 % -51.51 % -34.14 % -8.23 % -9.45 %
Seq. Cash & cash equivalent TTM Growth -35.52 % -37.88 % -38.18 % 7.37 % 14.88 %

Quick ratio ranking by company, industry and sector >> Back to BNKL Financial Strength Comparisons >> Go to Compare BNKL Quick Ratio to its Competitors

On the trailing twelve months basis Due to increase in Current Liabilities in the Q4 2023 to $2.31 millions, cumulative Quick Ratio decreased to 0.35 below the Bionik Laboratories Corp average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 251 other companies have achieved higher Quick Ratio than Bionik Laboratories . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the third quarter 2022 from 366 to 4597.

Explain Quick Ratio?
How much Cash & cash equivalents BNKL´s has?
What are BNKL´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 252
Healthcare Sector # 1185
Within the Market # 4597


trailing twelve months Quick Ratio Statistics
High Average Low
0.82 0.37 0.08
(Dec. 30, 2015)   (Mar 31 2018)




Companies with similar Quick Ratio in the quarter ending Mar 31 2023, within Medical Equipment & Supplies Industry Quick RatioMar 31 2023 MRQ Cash & cash equivalentMar 31 2023 MRQ Current Liabilities
Biolase Inc   0.51 $ 6.532  Millions$ 12.877  Millions
Guided Therapeutics Inc   0.50 $ 1.837  Millions$ 3.659  Millions
Streamex Corp   0.50 $ 1.412  Millions$ 2.814  Millions
Sientra Inc   0.50 $ 19.356  Millions$ 38.648  Millions
Pro dex Inc   0.49 $ 3.237  Millions$ 6.550  Millions
Icu Medical Inc  0.49 $ 227.417  Millions$ 462.177  Millions
Invo Fertility Inc   0.49 $ 2.188  Millions$ 4.450  Millions
Viewray Inc   0.49 $ 81.293  Millions$ 166.766  Millions
Msa Safety Inc  0.47 $ 138.906  Millions$ 292.531  Millions
Teleflex Incorporated  0.46 $ 264.138  Millions$ 575.712  Millions
Nu med Plus Inc   0.46 $ 0.053  Millions$ 0.116  Millions
Better Therapeutics Inc   0.44 $ 6.068  Millions$ 13.640  Millions
Angiodynamics Inc   0.43 $ 30.111  Millions$ 69.632  Millions
Heartbeam Inc   0.43 $ 0.990  Millions$ 2.320  Millions
Sep Acquisition Corp   0.42 $ 0.684  Millions$ 1.621  Millions
Strata Skin Sciences Inc  0.42 $ 2.825  Millions$ 6.738  Millions
Interpace Biosciences Inc   0.40 $ 5.596  Millions$ 13.851  Millions
Venus Concept Inc   0.39 $ 6.414  Millions$ 16.378  Millions
Meihua International Medical Technologies Co Ltd  0.38 $ 9.600  Millions$ 25.073  Millions
Lifestance Health Group Inc   0.38 $ 68.294  Millions$ 181.141  Millions
Orthofix Medical Inc   0.36 $ 49.968  Millions$ 137.568  Millions
Star Equity Holdings Inc   0.36 $ 8.714  Millions$ 24.206  Millions
Baxter International Inc   0.35 $ 1,673.000  Millions$ 4,760.000  Millions
Invacare Holdings Corporation  0.35 $ 66.284  Millions$ 188.592  Millions
Petvivo Holdings Inc   0.35 $ 0.503  Millions$ 1.454  Millions
Dexcom Inc   0.34 $ 623.200  Millions$ 1,833.200  Millions
Zimvie Inc   0.34 $ 66.414  Millions$ 196.528  Millions
Masimo Corp  0.33 $ 174.100  Millions$ 520.500  Millions
Oak Street Health Inc   0.30 $ 362.800  Millions$ 1,203.100  Millions
Stryker Corp  0.30 $ 1,757.000  Millions$ 5,866.000  Millions

Date modified: 2026-09-08T15:10:58+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.